The global measurement technology in downstream processing market was valued at USD 5.0 billion in 2022 and is projected to grow significantly, reaching USD 7.2 billion by 2028. This growth reflects the increasing demand for advanced measurement technologies in the pharmaceutical, biotechnology, and bioprocessing industries.
Downstream processing involves the recovery and purification of biosynthetic products, and precise measurement plays a crucial role in optimizing production efficiency and ensuring product quality. As industries focus on improving production yields, reducing costs, and meeting stringent regulatory standards, the need for reliable measurement technologies is driving market growth.
Key advancements in measurement technology, such as enhanced sensors, automation, and data analytics, are transforming downstream processing operations. These innovations enable more accurate and efficient monitoring of critical parameters such as temperature, pressure, pH, and flow rate, ensuring better control and improved outcomes during bioprocessing.
The market’s growth is further supported by the increasing investment in biopharmaceutical manufacturing, the expansion of contract manufacturing organizations (CMOs), and rising demand for biologics. North America holds the largest market share, driven by advanced biomanufacturing infrastructure, while regions such as Asia-Pacific are expected to experience significant growth due to expanding biopharma capabilities and manufacturing advancements.
What is COVID-19 Impact on measurement technology in downstream processing market?
The Covid-19 pandemic has created varied effects on the measurement technology in downstream processing market. While the initial days of the pandemic in 2020 were characterized by supply chain disruptions, the market has now effectively contended with these disruptions.
Though certain supply chain related alterations for the market are a permanent feature that will continue for at least the next ten years, the larger take away for the market is now in terms of consumption patterns and demand for measurement technology in downstream processing in terms of Products that are sought after.
Additionally, Consumer behavior connected to epidemiological stages and government responses to the pandemic is resulting in escalation, accumulation, and early recovery of the market.
Key Takeaways:
- The global measurement technology in downstream processing market is set to grow from USD 5.0 billion in 2022 to USD 7.2 billion by 2028.
- The demand for advanced measurement technologies is driven by the need for efficiency, quality control, and regulatory compliance in bioprocessing.
- Innovations in sensors, automation, and data analytics are transforming downstream processing operations.
- North America dominates the market, while Asia-Pacific is anticipated to experience robust growth due to increasing biopharmaceutical manufacturing activities.
Growth Drivers
- The increasing prevalence of chronic illnesses, such as cardiovascular diseases, cancers, and diabetes, is driving investments in the biologics market. This trend is expected to boost demand for measurement technologies that optimize biopharmaceutical production processes.
- The preference for purified biopharmaceutical products, which are associated with higher efficacy and fewer side effects compared to traditional small molecule drugs, further enhances the need for effective measurement technologies in downstream processing.
Key Trends
- The adoption of single-use measurement technologies is becoming more common due to their ease of use and reduced risk of cross-contamination, which is beneficial for both lab-scale and commercial-scale applications.
- The integration of advanced sensor technologies is crucial for improving product quality and stabilizing bioprocessing operations, thereby reducing manufacturing cycle times and capital costs.
Regional Insights
- The United States is anticipated to account for over 95.3% of the North American measurement technology market demand in 2022, driven by high adoption rates of automated bioprocessing systems.
- In Europe, particularly Germany, the market is expected to grow at a CAGR of 6.9%, supported by advancements in single-use unit measurement technologies that enhance analytical processes.
Competitive Landscape
Companies operating in the measurement technology in downstream processing market devices are actively seeking to strengthen their position through expansion, and merger & acquisition, with established as well as emerging market players.
Some of the recent instances include:
- In April 2021, Thermo Fisher Scientific Acquired PPD, Inc., a Leading Clinical Research Organization to Further expands service offering to pharma and biotech customers.
- In 2021, Sartorius strengthens its product portfolio with respect to cell and gene therapy by acquiring a key stake in CellGenix.
Key Companies Profiled
Applikon Biotechnology Inc.; Sartorius AG; Broadley-James Corporation; Thermo Fisher Scientific Inc.; Hamilton Company; Waters Corporation; PreSens Precision Sensing GmbH; PendoTECH LLC; Endress+Hauser AG; Mettler-Toledo International Inc.; Metroglas AG; Madison; YSI; Evoqua; Sensorex; Forbes
Get Full Report Now
Measurement technology in downstream processing market by Category
By Product:
- Sensors
- pH Sensors
- Optical
- Electrochemical
- DO Sensors
- Optical
- Eelctrochemical
- Conductivity Sensors
- Cell Density Sensors
- pH Sensors
- Sensor Housings
- Transmitters & Controllers
- Cables & Connectors
- Buffers & Reagents
By Modality:
- Single-use
- Reusable
By End User:
- Pharmaceutical & Biotechnology Companies
- Food & Beverage Companies
- Contract Manufacturing Organizations
- Academic & Research Institutes
- Others
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia-Pacific excluding Japan
- Japan
- Middle East & Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
